Could Eating More Healthy Fats Reduce Diabetes Risk? New Study Suggests It Can!The Diabetes Site
Although physicians consider weight loss of utmost importance in preventing or slowing the progression of diabetes in people with prediabetic conditions, a study published in March 2016 by King's College, London, suggests that consuming the right kind of fat may actually cause improvement in some patients. Analyzing a range of human subjects, researchers found that patients with Type 2 prediabetes may benefit from cutting down on saturated fats found in foods such as meat and cheese and increasing ingestion of polyunsaturated fats from sources such as vegetable oil and nuts.
As Tech Times explains, the researchers used data from people with various health backgrounds, including 14 athletes, 15 healthy people, 23 obese people, 10 people with prediabetic conditions and 11 people with Type 2 diabetes. They collected data through questionnaires about recent saturated and polyunsaturated fat consumption and measurements of fatty acid and blood glucose levels.
To effectively reach conclusions on the dietary adjustment of fats in treating diabetes, researchers divided patients with prediabetes into two groups according to the source of their conditions. Some people have prediabetic conditions because their livers manufacture an excess of glucose, while others have prediabetes because their muscles do not properly absorb glucose. The researchers discovered that both groups benefited from curtailing the amount of saturated fats that they consumed. However, only the group whose muscles did not take up glucose properly benefited from an increased intake of polyunsaturated fats. For those whose livers produced too much insulin, consuming more polyunsaturated fats did not improve their conditions.
This study provides one more piece of the complex puzzle of learning how people with diabetes and prediabetes can manage and improve their conditions. Read this for more information about ongoing research, and consider helping with a donation to assist researchers in learning more about effective therapies for early stage diabetes.